Bioengineering Innovative Solutions for Cancer
Coordonnateurs : Ladame Sylvain, Chang Jason
Bioengineering Innovative Solutions for Cancer bridges the gap between bioengineering and cancer biology. It focuses on a ?bottom up? understanding of the links between molecules, cells, tissues, organs, organisms, and health and functions?all within a bioengineering context. Chapters cover the main methods, technologies and devices that could help diagnose cancer sooner (e.g., ultrasensitive imaging and sensing technologies) and helpful treatments (e.g., new, more targeted therapies). The book takes an interdisciplinary approach that is ideal for those who need the latest information on design techniques and devices that help treat cancer using new, more targeted therapies.
By covering the many different ways engineers can deliver innovative solutions to tackle cancer, this book is a valuable read for researchers who have an ambition to make an impact on people?s life in either an academic or industrial setting.
2. Imaging
3. Cancer Therapy
4. In vitro models
Bioengineering postgraduate students (Master and PhD level)
Bioengineering academic researchers (RA, PDRA…)
Dr. Jason Y.H. Chang is currently a Postdoctoral research associate in Prof.Darrell Irvine’s lab at the Koch Institute at MIT, working on nanotechnologies for HIV vaccine development and detection of cell-free miRNA in cancer models. Prior to MIT, he obtained his MEng (Hons) in Product Design Engineering at Loughborough University in 2009, and then joined Imperial College London to obtain his MSc in Bioengineering in 2010, followed by an internship at University of Arizona working on developing a medium-throughput VE-cadherin screening assay. In 2011, he returned to Imperial College to pursue his PhD in ocular biomechanics and drug delivery with Prof. Darryl Overby, where he worked on the development of a peptide-based biosensor to detect nitric oxide production in the eye and drug delivery platforms to decrease elevated intraocular pressure the primary risk factor for glaucoma. During this time he was also a visiting researcher at Duke University (2013-2014) working with Prof. W Daniel Stamer on pharmacological interventions to alleviate ocular hypertension in both animal and human eyes. After completing his PhD in 2016, he joined the Ladame group to help develop different platform technologies for prostate cancer diagnosis ba
- Connects bioengineering and cancer biology, providing information on sensors, imaging, therapies and in-vitro models
- Presents the most comprehensive coverage in the field of cancer engineering to date
- Provides an academic introduction to (molecular) bioengineering for students, regardless of scientific background (math's, physics, chemistry, biology)
- Highlights the unmet medical needs for bioengineers and the main technological breakthroughs to cancer biologists
Date de parution : 11-2019
Ouvrage de 393 p.
19x23.3 cm
Thèmes de Bioengineering Innovative Solutions for Cancer :
Mots-clés :
Anatomical and functional imaging; Arterial spin labeling; Atomic force microscopy; Biosensor; Cancer; Cancer immunotherapy; Cancer surgery; Cell culture; Checkpoint blockade; Chemotherapy; Chimeric antigen receptor T cells (CAR T cells); Controlled release; Current; Cytoskeleton; Diagnostic; Diffusion tensor imaging (DTI); Diffusion-weighted imaging (DWI); Drug delivery; Dynamic contrast-enhanced (DCE) imaging; Electrode; Enzyme-linked immunosorbent assay; Exosomes; Flexible endoscopy; Fluorescent probes; Force generation; Harmonic imaging; Hydrogels; Imaging of cancer; Immune suppression; Impedance; In vitro; Lateral flow assay; Liquid biopsies; Magnetic resonance imaging (MRI); Mechanics; Mechanosensing; Metabolites; Microfluidic models; Microfluidics; Minimally invasive surgery; Molecular biomarkers; Molecular fluorophores; Nanoparticle; Nanotechnology; Natural orifice endoscopic surgery; Natural orifice transluminal endoscopic surgery; Neoantigen; Nucleic acids; Optical sensor; Organoids; Physics of MRI; Piezoelectric effect; Point-of-care testing; Potential; Predictive; Prognostic; Protein; Pulse-echo principle; Quantum dots; Robotic surgery; Traction force microscopy; Tumor microenvironment (TME); Tumor vaccines; Ultrasound contrast agents; Viscoelasticity; Voltammetry